CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that John (Jack) A. Schmidt, Jr., M.D., Chief Scientific Officer is leaving the company.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that John (Jack) A. Schmidt, Jr., M.D., Chief Scientific Officer is leaving the company.
